Heart Attacks, the Brain and Bone Marrow

People with recent heart attacks have significantly higher activity in the amygdala, the brain area involved in stress perception and emotional response, along with greater inflammation in arteries resulting from increased bone marrow activity, a hallmark of plaque build-up. But these levels are not permanent: In fact, they can all return to near-normal,  experts said.… Continue reading Heart Attacks, the Brain and Bone Marrow

Stopping Aspirin Therapy Can Be Dangerous: Study

Editor’s Note: Here, from the American Heart Association, an update on aspirin therapy and why it may be risky to quit it: Stopping long-term, low-dose aspirin therapy may increase your risk of suffering a cardiovascular event, according to new research in the American Heart Association’s journal Circulation. Aspirin, taken in low doses, is used to… Continue reading Stopping Aspirin Therapy Can Be Dangerous: Study

Mind-Body Medicine Can Ward Off Heart Attacks

Mind-body medicine (MBM) is a holistic approach that has the potential to ward off more heart attacks than conventional prevention programs. That is the conclusion reached by Holger Cramer and colleagues in a systematic review and meta-analysis presented in the November 2015 ssue of Deutsches Ärzteblatt. The team showed that MBM in cardiac patients has… Continue reading Mind-Body Medicine Can Ward Off Heart Attacks

Even When Heart Attack Patients Are in a Coma, Reducing Body Temperature Saves Brain Functions

Survivors of cardiac arrest who remain in comas have better survival and neurological outcomes when their body temperatures are lowered, according to research done in November 2015 by Dr. Sarah Perman at the University of Colorado Anschutz Medical Campus and published the journal Circulation. It was funded by the National Institutes of Health. A release… Continue reading Even When Heart Attack Patients Are in a Coma, Reducing Body Temperature Saves Brain Functions

The Latest on Pain Relievers: Answers from the FDA

Here, a Q & A with Sharon Hertz, Deputy Director of FDA’s Division of Anesthesia, Analgesia, and Rheumatology Products, who has been with FDA for 15 years. Dr. Hertz graduated from SUNY Upstate Medical Center in Syracuse, N.Y., and completed her residency in neurology at SUNY Health Sciences Center at Brooklyn. This Q&A reflects the… Continue reading The Latest on Pain Relievers: Answers from the FDA

The Truth About the Headlines Regarding Aspirin as a Preventive Measure

When the U.S. Preventive Services Task Force released a draft of a recommendation on September 15th 2015 regarding the use of aspirin to prevent heart disease and cancer, headlines heralding the news in both in print and online proliferated quickly. The New York Times blared “In a First, Aspirin Is Recommended to Fight a Form… Continue reading The Truth About the Headlines Regarding Aspirin as a Preventive Measure

Increased Risk of a Heart Attack Right After Joint Replacement Surgery

Boston-based researchers found that osteoarthritis patients who had total knee or hip joint replacement surgery known as arthroplasty were at increased risk of heart attacks (myocardial infarction) in the early post-operative period. However, the good news is that long-term risk of heart attacks did not persist. Yet the not-so-good news is that the risk for… Continue reading Increased Risk of a Heart Attack Right After Joint Replacement Surgery

Promoting Regeneration of Heart Tissue

A team led by Ed Morrisey, PhD, a professor of Medicine and Cell and Developmental Biology and the scientific director of the Institute for Regenerative Medicine in the Perelman School of Medicine at the University of Pennsylvania, has shown that a subset of RNA molecules, called microRNAs, is important for cardiomyocyte cell proliferation during development… Continue reading Promoting Regeneration of Heart Tissue